What the analyst said

Susquehanna analyst Mehdi Hosseini raised the price target on Applied Materials (NASDAQ: AMAT) to $500.00 (from $435.00) while maintaining a Positive rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

AMAT trades at $390. The 8 analysts who set a target in the last 3 months range from $563 to $850, with a median of $685. This $500 target is 27% below the median, the lowest on the Street.

Since the note AMAT has moved +1% (from $386). 12-month window: day 205 of 365, closes on April 9, 2027.

Track record

This call✓ Target reached on June 3, 2026, 2 months after the note.

Firm track recordSusquehanna: 91% of its 11 targets at least a year old were reached within 12 months. Accuracy ranking →

Susquehanna on Applied Materials

Susquehanna price targets on Applied Materials

3 calls from January 12, 2026 to June 30, 2026. The target went from $400 to $900 (+125%). The rating stayed Buy.

Susquehanna targetAMAT share price
  1. June 30, 2026Target raised from $500 (+80%)Buy$900
  2. April 9, 2026 This noteTarget raised from $400 (+25%)Buy$500
  3. January 12, 2026Earliest call shownBuy$400
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.